Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$571M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$508M |
| 3 |
Microsoft
MSFT
|
+$467M |
| 4 |
Apple
AAPL
|
+$443M |
| 5 |
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
|
+$343M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$1.4B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$416M |
| 3 |
Estee Lauder
EL
|
+$344M |
| 4 |
S&P Global
SPGI
|
+$310M |
| 5 |
TSG
The Stars Group Inc.
TSG
|
+$302M |
Sector Composition
| 1 | Technology | 16.45% |
| 2 | Financials | 10.63% |
| 3 | Consumer Discretionary | 9.66% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
First Financial Bankshares
FFIN
$5.12B
| $2.23M | ﹤0.01% |
77,333
+6,370
| +9% | +$184K |
|
|
TPTX
1527
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.23M | ﹤0.01% |
34,497
+10,784
| +45% | +$696K |
|
1528
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $2.23M | ﹤0.01% |
26,946
-112,315
| -81% | -$9.28M |
|
1529
Azenta
AZTA
$1.36B
| $2.22M | ﹤0.01% |
50,204
+14,123
| +39% | +$625K |
|
1530
Schwab US Dividend Equity ETF
SCHD
$71.5B
| $2.22M | ﹤0.01% |
128,463
-17,034
| -12% | -$294K |
|
1531
Apellis Pharmaceuticals
APLS
$3.14B
| $2.21M | ﹤0.01% |
67,785
+15,336
| +29% | +$501K |
|
1532
Trinity Industries
TRN
$2.28B
| $2.21M | ﹤0.01% |
103,666
+4,362
| +4% | +$92.9K |
|
1533
American Axle
AXL
$697M
| $2.2M | ﹤0.01% |
289,661
-121,981
| -30% | -$927K |
|
1534
Invesco Taxable Municipal Bond ETF
BAB
$922M
| $2.19M | ﹤0.01% |
66,590
+47,538
| +250% | +$1.56M |
|
1535
Banco Bilbao Vizcaya Argentaria
BBVA
$110B
| $2.18M | ﹤0.01% |
642,007
-53,150
| -8% | -$181K |
|
1536
iShares Short Maturity Bond ETF
NEAR
$3.55B
| $2.18M | ﹤0.01% |
43,575
+25,540
| +142% | +$1.28M |
|
|
SAGE
1537
DELISTED
Sage Therapeutics
SAGE
| $2.18M | ﹤0.01% |
52,348
-10,748
| -17% | -$447K |
|
1538
British American Tobacco
BTI
$123B
| $2.18M | ﹤0.01% |
56,026
-4,303
| -7% | -$167K |
|
|
ESGR
1539
DELISTED
Enstar Group
ESGR
| $2.17M | ﹤0.01% |
14,220
-2,135
| -13% | -$326K |
|
1540
Openlane
KAR
$3.07B
| $2.17M | ﹤0.01% |
157,605
-5,481
| -3% | -$75.4K |
|
1541
Navient
NAVI
$1.28B
| $2.17M | ﹤0.01% |
308,478
+69,101
| +29% | +$486K |
|
1542
Franklin Electric
FELE
$4.21B
| $2.17M | ﹤0.01% |
41,254
+22,582
| +121% | +$1.19M |
|
1543
ONE Gas
OGS
$4.55B
| $2.17M | ﹤0.01% |
28,108
+6,171
| +28% | +$476K |
|
1544
TD Synnex
SNX
$12.5B
| $2.17M | ﹤0.01% |
36,162
+14,676
| +68% | +$879K |
|
1545
ACI Worldwide
ACIW
$5.18B
| $2.16M | ﹤0.01% |
79,960
-21,524
| -21% | -$581K |
|
|
BCPC
1546
Balchem Corporation
BCPC
$5.07B
| $2.16M | ﹤0.01% |
22,736
+6,924
| +44% | +$657K |
|
1547
MACOM Technology Solutions
MTSI
$9.82B
| $2.14M | ﹤0.01% |
62,421
+30,862
| +98% | +$1.06M |
|
1548
iShares MSCI Canada ETF
EWC
$3.26B
| $2.14M | ﹤0.01% |
82,806
+34,013
| +70% | +$880K |
|
1549
Q2 Holdings
QTWO
$5.13B
| $2.14M | ﹤0.01% |
24,904
+5,282
| +27% | +$453K |
|
1550
Allogene Therapeutics
ALLO
$251M
| $2.14M | ﹤0.01% |
49,870
+4,254
| +9% | +$182K |
|